Robert T. Bailer

23.8k citations

79 papers · 5.9k indexed · 1 hit paper · h-index 42

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment

Papers in

Virology 40
- HIV Research and Treatment 38
Immunology 41
- Immune Cell Function and Interaction 18
- Immunotherapy and Immune Responses 16

Co-authors: John R. Mascola Richard A. Koup Barney S. Graham Mary E. Enama Gary J. Nabel Mario Roederer Michael S. Seaman David C. Montefiori
Journals: Journal of Virology (10 papers)PLoS ONE (9 papers)Vaccine (5 papers)The Journal of Infectious Diseases (5 papers)Clinical and Vaccine Immunology (3 papers)
Partner nations: United States China Switzerland

In The Last Decade

Robert T. Bailer

79 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody 2012 · 619 citations

Peers

Countries citing papers authored by Robert T. Bailer

Since Specialization

Citations

This map shows the geographic impact of Robert T. Bailer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Bailer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Bailer more than expected).

Fields of papers citing papers by Robert T. Bailer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Bailer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Bailer. The network helps show where Robert T. Bailer may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert T. Bailer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert T. Bailer Line = papers co-authored together Robert T. Bailer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial PLoS ONE ·Cristina Carter, Katherine V. Houser, Galina V. Yamshchikov, Abbie R. Bellamy, Jeanine May, Mary E. Enama, Uzma Sarwar, Brenda Larkin, Robert T. Bailer, Richard A. Koup, Grace Chen, Shital M. Patel, Patricia Winokur, Robert B. Belshe, Cornelia L. Dekker, Barney S. Graham, Julie E. Ledgerwood, (unknown)	2019	16
2	Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope Immunity ·Till Schoofs, Christopher O. Barnes, A N Prokhorov, Jovana Golijanin, Philipp Schommers, Henning Gruell, Anthony P. West, 欧惠平, Yu E. Lee, Lilian Nogueira, Ivelin S. Georgiev, Robert T. Bailer, Julie Czartoski, John R. Mascola, Michael S. Seaman, M. Juliana McElrath, Nicole A. Doria‐Rose, Florian Klein, Michel C. Nussenzweig, Pamela J. Björkman	2019	57
3	Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition Structure ·Gwo‐Yu Chuang, Jing Zhou, Priyamvada Acharya, Reda Rawi, Chen‐Hsiang Shen, Zizhang Sheng, Baoshan Zhang, Tongqing Zhou, Robert T. Bailer, Venkata P. Dandey, Nicole A. Doria‐Rose, Mark K. Louder, Krisha McKee, John R. Mascola, Lawrence Shapiro, Peter D. Kwong	2018	43
4	DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial PLoS ONE ·Katherine V. Houser, Galina V. Yamshchikov, Abbie R. Bellamy, Jeanine May, Mary E. Enama, Uzma Sarwar, Brenda Larkin, Robert T. Bailer, Richard A. Koup, Myeisha Paskel, Kanta Subbarao, Edwin L. Anderson, David I. Bernstein, Danny Zomerhuis, Harry Keyserling, Paul Spearman, Peter F. Wright, Barney S. Graham, Julie E. Ledgerwood, (unknown)	2018	23
5	Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults mAbs ·Yunda Huang, Lily Zhang, Julie E. Ledgerwood, Nicole Grunenberg, Robert T. Bailer, Abby Isaacs, Kelly E. Seaton, Kenneth H. Mayer, Edmund V. Capparelli, Lawrence Corey, Peter B. Gilbert	2017	26
6	Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection Cell ·Xueling Wu, Zhenhai Zhang, Chaim A. Schramm, Michael Joyce, Young Do Kwon, Tongqing Zhou, Zizhang Sheng, Baoshan Zhang, Sijy O’Dell, Krisha McKee, 羊久坂部, Gwo‐Yu Chuang, Nancy S. Longo, Rebecca M. Lynch, Kevin O. Saunders, Cinque Soto, Sanjay Srivatsan, Yongping Yang, Robert T. Bailer, Mark K. Louder, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2015	150
7	Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost Contemporary Clinical Trials ·Julie E. Ledgerwood, Zonghui Hu, Pamela Costner, Galina V. Yamshchikov, Mary E. Enama, Sarah H. Plummer, Cynthia S. Hendel, LaSonji A. Holman, Brenda Larkin, Ingelise J. Gordon, Robert T. Bailer, Donald M. Poretz, Uzma Sarwar, 梅昌新, Richard A. Koup, John R. Mascola, Barney S. Graham	2015	11
8	Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults PLoS ONE ·Michelle C. Crank, Ingelise J. Gordon, Galina V. Yamshchikov, Sandra Sitar, Zonghui Hu, Mary E. Enama, LaSonji A. Holman, Robert T. Bailer, Melissa B. Pearce, Richard A. Koup, John R. Mascola, Gary J. Nabel, Terrence M. Tumpey, Richard Schwartz, Barney S. Graham, Julie E. Ledgerwood, (unknown)	2015	20
9	Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors Clinical and Vaccine Immunology ·Robert Paris, Robert A. Kuschner, Leonard N. Binn, Stephen J. Thomas, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Robert T. Bailer, Nancy J. Sullivan, Richard A. Koup	2014	14
10	Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial PLoS ONE ·Uzma Sarwar, Laura Novik, Mary E. Enama, Е. Г. Свиридов, Richard A. Koup, Martha Nason, Robert T. Bailer, Adrian B. McDermott, Mario Roederer, John R. Mascola, Julie E. Ledgerwood, Barney S. Graham, (unknown)	2014	5
11	Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1 Journal of Immunological Methods ·Marcella Sarzotti‐Kelsoe, Robert T. Bailer, Esra Abacı Türk, L Curti, Miroslawa Bilska, Kelli Greene, Hongmei Gao, Christopher A. Todd, Daniel A. Ozaki, Michael S. Seaman, John R. Mascola, David C. Montefiori	2013	290
12	Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses PLoS ONE ·Richard A. Koup, Mario Roederer, Laurie Lamoreaux, Jennifer Fischer, Laura Novik, Martha Nason, Brenda Larkin, Mary E. Enama, Julie E. Ledgerwood, Robert T. Bailer, John R. Mascola, Gary J. Nabel, Barney S. Graham, (unknown)	2010	102
13	Systemic and Mucosal T-Lymphocyte Activation Induced by Recombinant Adenovirus Vaccines in Rhesus Monkeys Journal of Virology ·Yue Sun, Robert T. Bailer, Srinivas S. Rao, John R. Mascola, Gary J. Nabel, Richard A. Koup, Norman L. Letvin	2009	14
14	A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial Vaccine ·Julie E. Martin, Mark K. Louder, L. Marcinowski, Ingelise J. Gordon, Mary E. Enama, Brenda Larkin, Charla Andrews, Leatrice Vogel, Richard A. Koup, Mario Roederer, Robert T. Bailer, Phillip L. Gomez, Martha Nason, John R. Mascola, Gary J. Nabel, Barney S. Graham	2008	197
15	Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses The Journal of Experimental Medicine ·Melissa Precopio, Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher, Daniel C. Douek, Alexandre Harari, Giuseppe Pantaleo, Robert T. Bailer, Barney S. Graham, Mario Roederer, Richard A. Koup	2007	378
16	A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial The Journal of Infectious Diseases ·Julie E. Martin, Theodore C. Pierson, Ilka Peter, Faye Messner, Ingelise J. Gordon, Mary E. Enama, Charla Andrews, Qing Xu, Brent S. Davis, Martha Nason, Michael P. Fay, Richard A. Koup, Mario Roederer, Robert T. Bailer, Phillip L. Gomez, John R. Mascola, Gwong‐Jen J. Chang, Gary J. Nabel, Barney S. Graham	2007	131
17	Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients Virology ·Hui Peng, Litao Yang, Lingyun Wang, Jian Li, Jun Huang, Kevin Lu, Richard A. Koup, Robert T. Bailer, Changyou Wu	2006	114
18	Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine The Journal of Infectious Diseases ·Barney S. Graham, Richard A. Koup, Mario Roederer, Robert T. Bailer, Mary E. Enama, Zoe Moodie, Julie E. Martin, 隆之小野, Bimal K. Chakrabarti, Laurie Lamoreaux, Charla Andrews, Phillip L. Gomez, John R. Mascola, Gary J. Nabel	2006	151
19	Inhibition of IL-12 Production in Human Monocyte-Derived Macrophages by TNF The Journal of Immunology ·Xiaojing Ma, Junwei Sun, Emmanouil Papasavvas, Helge Riemann, Susan Robertson, Jason D. Marshall, Robert T. Bailer, Anne Moore, Raymond P. Donnelly, Giorgio Trinchieri, Luis J. Montaner	2000	97
20	Constitutive cytokine release by simian T‐cell lymphotrophic virus type I (STLV‐I) and human T‐cell lymphotrophic virus types I/II (HTLV‐I/II) transformed cell lines Journal of Medical Primatology ·Yao Chang-mo, Robert T. Bailer	1996	5

About Robert T. Bailer

Robert T. Bailer is a scholar working on Virology, Immunology, Infectious Diseases, Epidemiology and Molecular Medicine, having authored 79 papers that have together received 5.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (16 papers), vaccines and immunoinformatics approaches (11 papers), Influenza Virus Research Studies (10 papers), Hepatitis B Virus Studies (10 papers), HIV/AIDS drug development and treatment (10 papers) and Herpesvirus Infections and Treatments (9 papers). The work is most often cited by research in Virology (2.7k citations), Infectious Diseases (2.5k citations), Immunology (2.5k citations), Epidemiology (1.6k citations) and Radiology, Nuclear Medicine and Imaging (763 citations). Robert T. Bailer has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include John R. Mascola, Richard A. Koup, Barney S. Graham, Mary E. Enama, Gary J. Nabel, Mario Roederer, Michael S. Seaman, David C. Montefiori, Charla Andrews and Phillip L. Gomez. Their work appears in journals such as Journal of Virology, PLoS ONE, Vaccine, The Journal of Infectious Diseases and Clinical and Vaccine Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact